Phase II Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 18 Jun 2012 Actual end date changed from 1 Oct 2009 to 1 Dec 2007 as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2008 Status changed from recruiting to in progress.